Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
Open Access
- 1 June 2017
- journal article
- review article
- Published by Elsevier BV in Neuron
- Vol. 94 (6), 1056-1070
- https://doi.org/10.1016/j.neuron.2017.04.010
Abstract
No abstract availableKeywords
Funding Information
- NIH National Institute of Neurological Disorders and Stroke (R01NS097816)
- National Institute of Aging (R21AG044719)
This publication has 126 references indexed in Scilit:
- Electrophysiological biomarkers in spinal muscular atrophy: proof of conceptAnnals of Clinical and Translational Neurology, 2013
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin SynthesisNeuron, 2012
- Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyThe Lancet Neurology, 2012
- Propagation of Tau Pathology in a Model of Early Alzheimer's DiseaseNeuron, 2012
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALSNeuron, 2011
- The Many Faces of TauNeuron, 2011
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic MiceAmerican Journal of Human Genetics, 2008
- Antisense inhibition at the β-secretase-site of β-amyloid precursor protein reduces cerebral amyloid and acetyl cholinesterase activity in Tg2576Neuroscience, 2007
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993